arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Tenaya Therapeutics, Inc.

TNYA Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$0.39
▲ +0.3% Today
as of Oct 23, 14:21 ET
Last 30 days -43.55% Sep 14 → Oct 23
$0.35 $0.44 $0.54 $0.63 $0.72 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$0.40
High
$0.41
Low
$0.39
Volume
$2M
Avg Vol
$4M
Mkt Cap
$127M
P/E (TTM)
—
Beta
—
52w High
$1.74
52w Low
$0.36
Div Yield
—
Shares Out
$224M

Recent Press Releases & News last 60 days · 2 items

Sep 14 · 12:30 PR GlobeNewswire
Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
Sep 3 · 20:30 PR GlobeNewswire
Tenaya Therapeutics to Participate in Upcoming September Investor Conferences

TNYA earnings at a glance

The options market is pricing a move of about ±27.9% after the report, a range of roughly $0.28 to $0.50 from today's $0.39. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±4.2% on average; after the most recent report on May 6, 2026 it moved +4.8%. That means options currently expect more movement than TNYA has typically delivered. TNYA beat the consensus EPS estimate in 2 of its last 4 reported quarters. Implied volatility is currently 236%. The share price of $0.39 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.36
$1.74
2% of range
Avg surprise (last 4)
+4.2%
Avg reaction (last 2)
+0.6%
50% positive
Latest IV / EM
236%
EM ±27.9% · $1 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.45$-0.36$-0.27$-0.18$-0.09 Actual $-0.43Actual $-0.45Actual $-0.39Actual $-0.40Actual $-0.34Actual $-0.30Actual $-0.24Est $-0.18Actual $-0.14Est $-0.20Actual $-0.12Est $-0.15Actual $-0.09Est $-0.09Actual $-0.20 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-43M$-32M$-21M$-10M$1M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.20 — — — — financials
Wed May 6, 2026Mar/2026 $-0.09 $-0.09 0.0% +62.5% +4.8% earnings
Mon Nov 10, 2025Sep/2025 $-0.12 $-0.15 +20.0% — — earnings
Wed Aug 6, 2025Jun/2025 $-0.14 $-0.20 +30.0% — — earnings
Wed May 7, 2025Mar/2025 $-0.24 $-0.18 -33.3% — -3.6% earnings
Mon Sep 30, 2024Sep 2024 $-0.30 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.34 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.40 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.39 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.45 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.43 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$1M$225,000——$0$0——
Cost of revenue————————
Gross profit————————
Operating income$-44M$-20M—$-21M$-24M$-28M—$-27M
Net income$-43M$-19M—$-20M$-23M$-27M—$-26M
EPS (diluted)$-0.20$-0.09—$-0.12$-0.14$-0.24—$-0.30

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$78M$81M$101M$56M$63M$54M$4M$8M
Inventory————————
Total current assets$86M$97M$106M$61M$76M$94M$67M$85M
Total assets$94M$135M$147M$105M$122M$144M$120M$141M
Long-term debt————————
Total liabilities$24M$29M$24M$22M$22M$25M$27M$28M
Total equity$69M$106M$123M$83M$100M$119M$93M$113M

Implied volatility — last 90 days

127%375%623%871%1119% Jun 11 — IV 965% · EM ±106.7%Jun 19 — IV 310% · EM ±68.4%Jun 22 — IV 308% · EM ±64.3%Jun 23 — IV 264% · EM ±53.9%Jun 24 — IV 274% · EM ±54.9%Jun 25 — IV 395% · EM ±77.5%Jun 26 — IV 475% · EM ±91.0%Jun 29 — IV 350% · EM ±62.0%Jun 30 — IV 387% · EM ±66.7%Jul 01 — IV 448% · EM ±74.8%Jul 02 — IV 982% · EM ±158.8%Jul 03 — IV 976% · EM ±152.5%Jul 06 — IV 127% · EM ±17.6%Jul 14 — IV 1119% · EM ±81.0%Jul 27 — IV 583% · EM ±121.7%Aug 14 — IV 802% · EM ±88.6%Aug 25 — IV 967% · EM ±197.9%Sep 11 — IV 848% · EM ±93.8%Sep 15 — IV 722% · EM ±52.2%Sep 21 — IV 284% · EM ±59.3%Sep 22 — IV 321% · EM ±65.7%Sep 23 — IV 298% · EM ±59.7%Sep 24 — IV 284% · EM ±55.6%Sep 25 — IV 211% · EM ±40.4%Sep 28 — IV 189% · EM ±33.5%Sep 30 — IV 298% · EM ±49.7%Oct 01 — IV 263% · EM ±42.6%Oct 02 — IV 284% · EM ±44.3%Oct 06 — IV 338% · EM ±44.7%Oct 07 — IV 362% · EM ±45.4%Oct 08 — IV 236% · EM ±27.9%

Sector peers

ENGN
enGene Therapeutics Inc.
$128M $1.56-4.3%
ARMP
Armata Pharmaceuticals, Inc.
$123M $3.71+21.2%
CRBU
Caribou Biosciences, Inc.
$131M $0.540.0%
HUMA
Humacyte, Inc.
$140M $0.43+3.9%
LENZ
LENZ Therapeutics, Inc.
$114M $3.10-3.9%
MOLN
Molecular Partners AG
$143M $3.67-1.3%

TNYA earnings FAQ

What is TNYA's expected move for earnings?

Options currently price a move of about ±27.9%, or $0.11 per share either way from $0.39.

How does TNYA stock usually react to earnings?

Across the last 2 reports the average next-day move was ±4.2%, up 1 times and down 1 times.

What is TNYA's implied volatility?

TNYA's at-the-money implied volatility is about 236% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in